Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126110113 | 12611011 | 3 | F | 2014 | 20160909 | 20160801 | 20160915 | PER | US-PFIZER INC-2016362810 | PFIZER | 46.00 | YR | F | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126110113 | 12611011 | 1 | PS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, 4X/DAY | N01250 | 84349 | 100 | MG | CAPSULE, HARD | QID | |||||
| 126110113 | 12611011 | 2 | SS | DILANTIN | PHENYTOIN | 1 | 84349 | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126110113 | 12611011 | 1 | Epilepsy |
| 126110113 | 12611011 | 2 | Seizure |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126110113 | 12611011 | Drug ineffective | |
| 126110113 | 12611011 | Progesterone abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |